CCL20 and neoplasm: Tao Fan et al. (2022) suggested that the activity of CCL20 appears to be linked to the tumor’s non-response to immunotherapy when linking to TGF-β, blocking the immune checkpoint receptor, and promoting the metastatic diffusion [11,12].